CW January 2006
Volume 15Issue Number 1 January 2006 ISSN 10593802 Revlimid Effective in Newly Diagnosed Multiple MyelomaA new oral agent for treating multiple myeloma shows efficacy in newly diagnosed multiple myeloma patients with fewer non-hematologic side effects than the current standard Rev/Dex.
Go to Previous Page Go to Next Page Source & Additional Reading S. V. Rajkumar, 47th Annual Meeting & Exposition of the American Society of Hematology. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW January 2006Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
